Page last updated: 2024-08-23

piperacillin and fosfomycin

piperacillin has been researched along with fosfomycin in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19904 (16.00)18.7374
1990's5 (20.00)18.2507
2000's9 (36.00)29.6817
2010's6 (24.00)24.3611
2020's1 (4.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P1
Brown-Driver, V; Finn, J; Haselbeck, RJ; Hilgers, MT; Kedar, GC; Reyes, DR; Shaw, KJ; Stidham, MA1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Cars, O; Löwdin, E; Melhus, A; Tängdén, T1
Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Capri, S; Del Bono, GP; Dellamano, R1
Kuzui, H; Murakami, T; Nishino, T; Obana, Y1
Kawamura, M; Kuyama, T; Miyamoto, M; Sudo, T1
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R1
Hayashi, T; Katahira, J; Kitayama, R; Kumada, T; Kumano, K; Muratani, T; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T1
Hayashi, T; Katahira, J; Kitayama, R; Kumada, T; Kumano, K; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T1
Haag, R1
Kanno, H; Takahashi, K1
Georgieff, M; Konrad, F; Neumeister, B; Rommel, H; Wagner, R1
Araake, M; Hara, T; Tsuruoka, T; Watabe, H1
Lin, CT; Peng, HL1
Ammann, RA; Bode, U; Engelhart, S; Fleischhack, G; Gröger, N; Hasan, C; Kramer, MH; Simon, A; Wilkesmann, A; Wiszniewsky, G1
Chakraborty, T; Fritzenwanker, M; Herold, S; Imirzalioglu, C; Wagenlehner, FM; Zimmer, KP1
Harris, PNA1
Chusri, S; Ontong, JC; Ozioma, NF; Voravuthikunchai, SP1

Reviews

2 review(s) available for piperacillin and fosfomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Treatment Options for Carbapenem- Resistant Gram-Negative Infections.
    Deutsches Arzteblatt international, 2018, 05-21, Volume: 115, Issue:20-21

    Topics: Aminoglycosides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Therapy, Combination; Escherichia coli; Fluoroquinolones; Fosfomycin; Germany; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Tigecycline

2018

Other Studies

23 other study(ies) available for piperacillin and fosfomycin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
    Journal of medicinal chemistry, 2007, Aug-23, Volume: 50, Issue:17

    Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship

2007
Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6

    Topics: Alkyl and Aryl Transferases; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Proteins; Drug Resistance, Bacterial; Fosfomycin; Inhibitory Concentration 50; Microbial Sensitivity Tests; RNA, Antisense

2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult

2010
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction

2010
Cost-effectiveness comparison of single and multiple-dose antibiotic treatment of lower uncomplicated urinary tract infections.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosfomycin; Humans; Piperacillin; Time Factors; Tromethamine; Urinary Tract Infections

1992
[Bacterial combination effect between carumonam and eight other antibiotics].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:12

    Topics: Animals; Aztreonam; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Female; Fosfomycin; Gentamicins; Mice; Piperacillin; Proteus vulgaris; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections

1990
Assessment of antimicrobial penetration into the pancreatic juice in dogs.
    Nihon geka hokan. Archiv fur japanische Chirurgie, 1990, May-01, Volume: 59, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Ceftizoxime; Dogs; Female; Fosfomycin; Male; Netilmicin; Pancreatic Juice; Piperacillin

1990
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of pipera
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftazidime; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Moxalactam; Piperacillin; Sulbactam

1990
Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:4

    Topics: Animals; Blood Urea Nitrogen; Cisplatin; Fosfomycin; Kidney; Kidney Diseases; Leukemia L1210; Male; Piperacillin; Platinum; Rats; Rats, Inbred F344

1989
Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:6

    Topics: Animals; Cephaloridine; Cephalothin; Fosfomycin; Gentamicins; Kidney Cortex; Kidney Diseases; Kidney Medulla; Male; Piperacillin; Rabbits; Rats; Rats, Inbred Strains

1988
Fosfomycin, piperacillin, azlocillin. Correlation between therapeutic response of mice infected with Pseudomonas aeruginosa and in vitro data.
    Chemotherapy, 1984, Volume: 30, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Azlocillin; Fosfomycin; Kinetics; Mice; Microbial Sensitivity Tests; Models, Biological; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections

1984
Synergistic activities of combinations of beta-lactams, fosfomycin, and tobramycin against Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:5

    Topics: Anti-Bacterial Agents; Cefoperazone; Cefsulodin; Drug Synergism; Fosfomycin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tobramycin

1984
Studies on drug monitoring in thrice and once daily treatment with aminoglycosides.
    Intensive care medicine, 1993, Volume: 19, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Metronidazole; Middle Aged; Netilmicin; Piperacillin; Respiration, Artificial; Staphylococcal Infections; Teicoplanin

1993
[Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
    The Japanese journal of antibiotics, 2003, Volume: 56, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Cefmetazole; Cefotiam; Coagulase; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fosfomycin; Methicillin; Piperacillin; Staphylococcus; Staphylococcus aureus

2003
Regulation of the homologous two-component systems KvgAS and KvhAS in Klebsiella pneumoniae CG43.
    Journal of biochemistry, 2006, Volume: 140, Issue:5

    Topics: Amino Acid Sequence; Bacterial Proteins; Carbenicillin; Cephalothin; Electrophoretic Mobility Shift Assay; Fosfomycin; Gene Deletion; Gene Expression Regulation, Bacterial; Histidine Kinase; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Piperacillin; Promoter Regions, Genetic; Protein Kinases; Sigma Factor; Signal Transduction; Transcription Factors

2006
Restricted use of glycopeptides in paediatric cancer patients with fever and neutropenia.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:5

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Fosfomycin; Glycopeptides; Humans; Infant; Length of Stay; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Teicoplanin; Treatment Outcome

2006
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-27, Volume: 69, Issue:12

    Topics: Fosfomycin; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections

2019
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
    PloS one, 2021, Volume: 16, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Fosfomycin; Klebsiella pneumoniae; Piperacillin; Tetracyclines

2021